Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE220462 | GEO | 2024/05/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (scRNA-seq)

Project description:To examine the transcriptomic changes in Upf2 KO neural progenitors at a single cell level, we performed scRNA-seq using the 10x Chromium platform.

2024-05-30 | GSE220461 | GEO

Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (RNA-seq e13invivo)

Project description:To determine the transcriptomic impacts of NMD on lineage transition in vivo, we performed mRNA-Seq of neocortices from E13.5 Emx1-Upf2cKO and their control littermates.

2024-05-30 | GSE220460 | GEO

Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (RNA-seq NPC)

Project description:We performed mRNA-Seq of Upf2 KO, Trp53 KO, and dKO NPC.

2024-05-30 | GSE220459 | GEO

Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size

Project description:Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size

| PRJNA909801 | ENA

Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (scRNA-seq)

Project description:Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (scRNA-seq)

| PRJNA909810 | ENA

Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (RNA-seq NPC)

Project description:Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (RNA-seq NPC)

| PRJNA909807 | ENA

Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (RNA-seq e13invivo)

Project description:Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size (RNA-seq e13invivo)

| PRJNA909808 | ENA

Olfactory control of blood progenitor maintenance.

Project description:Drosophila hematopoietic progenitor maintenance involves both near neighbor and systemic interactions. This study shows that olfactory receptor neurons (ORNs) function upstream of a small set of neurosecretory cells that express GABA. Upon olfactory stimulation, GABA from these neurosecretory cells is secreted into the circulating hemolymph and binds to metabotropic GABAB receptors expressed on blood progenitors within the hematopoietic organ, the lymph gland. The resulting GABA signal causes high cytosolic Ca(2+), which is necessary and sufficient for progenitor maintenance. Thus, the activation of an odorant receptor is essential for blood progenitor maintenance, and consequently, larvae raised on minimal odor environments fail to sustain a pool of hematopoietic progenitors. This study links sensory perception and the effects of its deprivation on the integrity of the hematopoietic and innate immune systems in Drosophila. PAPERCLIP:

| S-EPMC3865989 | biostudies-literature

Glucocorticoids improve erythroid progenitor maintenance and dampen Trp53 response in a mouse model of Diamond-Blackfan anaemia.

Project description:Diamond-Blackfan anaemia (DBA) is a rare congenital disease causing severe anaemia and progressive bone marrow failure. The majority of patients carry mutations in ribosomal proteins, which leads to depletion of erythroid progenitors in the bone marrow. As many as 40% of all DBA patients receive glucocorticoids to alleviate their anaemia. However, despite their use in DBA treatment for more than half a century, the therapeutic mechanisms of glucocorticoids remain largely unknown. Therefore we sought to study disease specific effects of glucocorticoid treatment using a ribosomal protein s19 (Rps19) deficient mouse model of DBA. This study determines for the first time that a mouse model of DBA can respond to glucocorticoid treatment, similar to DBA patients. Our results demonstrate that glucocorticoid treatment reduces apoptosis, rescues erythroid progenitor depletion and premature differentiation of erythroid cells. Furthermore, glucocorticoids prevent Trp53 activation in Rps19-deficient cells- in a disease-specific manner. Dissecting the therapeutic mechanisms behind glucocorticoid treatment of DBA provides indispensible insight into DBA pathogenesis. Identifying mechanisms important for DBA treatment also enables development of more disease-specific treatments of DBA.

| S-EPMC5014181 | biostudies-literature

A general model for multilocus epistatic interactions in case-control studies.

Project description:BACKGROUND: Epistasis, i.e., the interaction of alleles at different loci, is thought to play a central role in the formation and progression of complex diseases. The complexity of disease expression should arise from a complex network of epistatic interactions involving multiple genes. METHODOLOGY: We develop a general model for testing high-order epistatic interactions for a complex disease in a case-control study. We incorporate the quantitative genetic theory of high-order epistasis into the setting of cases and controls sampled from a natural population. The new model allows the identification and testing of epistasis and its various genetic components. CONCLUSIONS: Simulation studies were used to examine the power and false positive rates of the model under different sampling strategies. The model was used to detect epistasis in a case-control study of inflammatory bowel disease, in which five SNPs at a candidate gene were typed, leading to the identification of a significant three-locus epistasis.

| S-EPMC2909900 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data